HPS Pharmacies wish to give notice that there is a supply interruption for phenoxymethylpenicillin as follows:
|Cilicaine VK 250mg capsules||55675||Late February 2020|
|Cilicaine VK 500mg capsules||55676||Late February 2020|
|Aspecillin VK 250mg tablets||200136||Early April 2020|
|Aspecillin VK 500mg tablets||200137||Early April 2020|
|LPV® 250mg capsules||66510||Early April 2020|
|LPV® 500mg capsules||66511||End February 2020|
An internationally registered brand of phenoxymethylpenicillin 250mg and 500mg tablets are available under Section 19A of the Therapeutic Goods Act 1989. Please note that Section 19A alternatives are subject to a longer lead time and different pricing as they must be sourced internationally.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates